Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.21 is in line with its 5-year average of 4.63, around the middle of its 5-year range (0.23–7.53).
As of the fiscal period ended Friday, July 31, 2026. 25.19% below its 12-month average of 5.63.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-07-31): 4.21.
CURRENT RATIO
4.21
CURRENT RATIO AVG TTM
5.63
CURRENT RATIO AVG 3Y
4.77
CURRENT RATIO AVG 5Y
4.63
CURRENT RATIO AVG 10Y
3.00
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-25.19%
CURRENT VS 3Y AVG
-11.67%
CURRENT VS 5Y AVG
-9.08%
CURRENT VS 10Y AVG
+40.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+12.29%
vs the sector median at left
Market Cap
$82.91M
Current Ratio
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$79.40M
Current Ratio
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$83.22M
Current Ratio
16.14
TTM Avg
3.54
3Y Avg
1.85
5Y Avg
1.85
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $81.38M | 4.21 | 5.63 | 4.77 | 4.63 |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.08M | 3.30 | 5.38 | 8.10 | 12.75 |
| LENSAR Inc (LNSR)vs › | $82.47M | 2.39 | 1.97 | 2.72 | 3.82 |
| MediciNova, Inc. (MNOV)vs › | $82.70M | 8.75 | 11.02 | 14.04 | 18.21 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.91M | 7.85 | 4.70 | 2.98 | 5.25 |
| Humacyte, Inc. (HUMA)vs › | $79.83M | 6.21 | 3.04 | 4.62 | 7.16 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.40M | 7.99 | 9.12 | 12.06 | 14.25 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $83.22M | 16.14 | 3.54 | 1.85 | 1.85 |
| Citius Oncology, Inc. (CTOR)vs › | $79.06M | 0.73 | 0.45 | 0.43 | 0.43 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 7.03 | 3.05 | 3.90 | 4.20 |
Current Ratio
4.21
Quick Ratio
4.02
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-07-31 | 4.21 |
| 2026-04-30 | 5.26 |
| 2026-01-31 | 6.36 |
| 2025-10-31 | 7.53 |
| 2025-07-31 | 4.78 |
| 2025-04-30 | 3.71 |
| 2025-01-31 | 4.88 |
| 2024-10-31 | 4.96 |
| 2024-07-31 | 6.57 |
| 2024-04-30 | 6.16 |
| 2024-01-31 | 1.02 |
| 2023-10-31 | 2.79 |
| 2023-07-31 | 3.74 |
| 2023-04-30 | 2.54 |
| 2023-01-31 | 3.60 |
| 2022-10-31 | 4.44 |
| 2022-07-31 | 5.12 |
| 2022-04-30 | 6.42 |
| 2022-01-31 | 7.01 |
| 2021-10-31 | 5.92 |
| 2021-07-31 | 0.23 |
| 2021-04-30 | 0.37 |
| 2021-01-31 | 0.12 |
| 2020-10-31 | 0.13 |
| 2020-07-31 | 0.10 |
| 2020-04-30 | 0.09 |
| 2020-01-31 | 0.02 |
| 2019-10-31 | 0.19 |
| 2019-07-31 | 0.21 |
| 2019-04-30 | 0.72 |
| 2019-01-31 | 1.47 |
| 2018-10-31 | 2.12 |
| 2018-07-31 | 7.51 |
| 2018-04-30 | 0.69 |
| 2018-01-31 | 3.80 |
| 2017-10-31 | 0.81 |
| 2017-07-31 | 3.14 |
| 2017-04-30 | 0.43 |
| 2017-01-31 | 2.58 |
| 2016-10-31 | 0.37 |
| 2016-07-31 | 1.02 |
| 2016-04-30 | 2.46 |
| 2016-01-31 | 0.03 |
